Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ongoing evaluation of Pharmacia & Upjohn's new water-soluble camptothecin derivative

June 7, 1996

New 5-FU molecular combination merits further study

June 7, 1996

Development of AccuSite for basal cell carcinoma delayed

June 7, 1996

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

May 31, 1996

Walter Reed Army Institute technology licensed to Jenner Technologies

May 31, 1996

Sandoz reports complex for radiotherapy of somatostatin receptor-positive cancers

May 31, 1996

OC104-26 identified as multidrug resistance (MDR)-reversing agent

May 31, 1996

ISIS-7597, an antisense oligonucleotide, shows promise in battling multidrug resistance

May 31, 1996

A highly lipophilic delta7-PGAI analogue, TEI-9826, demonstrates antitumor activity

May 31, 1996

Sulfone metabolite of sulindac induces apoptosis

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 12, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.